| scholarly article | Q13442814 |
| P50 | author | Nadia Rosenthal | Q6957721 |
| P2093 | author name string | Jennifer Fang | |
| Richard T Lee | |||
| P Christian Schulze | |||
| Mihaela Cupesi | |||
| Kimberly A Kassik | |||
| Cathy MacGillivray | |||
| Joe Gannon | |||
| P433 | issue | 5 | |
| P921 | main subject | ventricular dysfunction | Q54911334 |
| overexpression | Q61643320 | ||
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 418-426 | |
| P577 | publication date | 2005-07-28 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Transgenic overexpression of locally acting insulin-like growth factor-1 inhibits ubiquitin-mediated muscle atrophy in chronic left-ventricular dysfunction | |
| P478 | volume | 97 |
| Q40034287 | A naturally occurring calcineurin variant inhibits FoxO activity and enhances skeletal muscle regeneration |
| Q33869877 | Activated protein synthesis and suppressed protein breakdown signaling in skeletal muscle of critically ill patients |
| Q37110291 | Activation of the ubiquitin-proteasome pathway in the diaphragm in chronic obstructive pulmonary disease |
| Q26767412 | Aerobic Exercise and Pharmacological Therapies for Skeletal Myopathy in Heart Failure: Similarities and Differences |
| Q40445265 | Analysis of angiogenesis induced by local IGF-1 expression after myocardial infarction using microSPECT-CT imaging |
| Q34781822 | Analysis of skeletal muscle gene expression patterns and the impact of functional capacity in patients with systolic heart failure |
| Q36445136 | Angiotensin II as candidate of cardiac cachexia |
| Q53640070 | Angiotensin II can directly induce mitochondrial dysfunction, decrease oxidative fibre number and induce atrophy in mouse hindlimb skeletal muscle. |
| Q37099711 | Angiotensin II inhibits satellite cell proliferation and prevents skeletal muscle regeneration |
| Q54590411 | Atrogin-1/MAFbx and MuRF1 are downregulated in aging-related loss of skeletal muscle. |
| Q27012762 | Cellular and molecular mechanisms of muscle atrophy |
| Q34785071 | Chronic heart failure reduces Akt phosphorylation in human skeletal muscle: relationship to muscle size and function |
| Q51064860 | Citrulline enhances myofibrillar constituents expression of skeletal muscle and induces a switch in muscle energy metabolism in malnourished aged rats. |
| Q34409450 | Cofilin Phosphorylation Decreased by Serum-free Starvation with Low Glucose in the L6 Myoblasts |
| Q35432628 | Controlled release of IGF-1 and HGF from a biodegradable polyurethane scaffold |
| Q36219633 | Doxorubicin and NRG-1/erbB4-Deficiency Affect Gene Expression Profile: Involving Protein Homeostasis in Mouse. |
| Q39090266 | Exercise capacity, physical activity, and morbidity. |
| Q37832481 | Exercise intolerance in chronic heart failure: mechanisms and therapies. Part I. |
| Q28481996 | Exercise training prevents oxidative stress and ubiquitin-proteasome system overactivity and reverse skeletal muscle atrophy in heart failure |
| Q48023234 | Experimental Evidences Supporting the Benefits of Exercise Training in Heart Failure |
| Q39721900 | Formoterol decreases muscle wasting as well as inflammation in the rat model of rheumatoid arthritis |
| Q37758421 | Functional electrical stimulation of lower limbs in patients with chronic heart failure |
| Q38638011 | Ginsenoside Rg1 prevents starvation-induced muscle protein degradation via regulation of AKT/mTOR/FoxO signaling in C2C12 myotubes |
| Q48218551 | Growth Hormone (GH) and Cardiovascular System |
| Q36503403 | Heart failure: a model of cardiac and skeletal muscle energetic failure. |
| Q39293713 | High-Methionine Diet Attenuates Severity of Arthritis and Modulates IGF-I Related Gene Expressions in an Adjuvant Arthritis Rats Model |
| Q36979025 | Implications of chronic heart failure on peripheral vasculature and skeletal muscle before and after exercise training |
| Q26753187 | In Vivo Rodent Models of Skeletal Muscle Adaptation to Decreased Use |
| Q33793116 | Increase in insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 1 after supplementation with selenium and coenzyme Q10. A prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens |
| Q35787728 | Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy |
| Q43281822 | Insulin-like growth factor-I and genetic effects on indexes of protein degradation in response to feed deprivation in rainbow trout (Oncorhynchus mykiss). |
| Q38052031 | Metabolic and structural impairment of skeletal muscle in heart failure |
| Q37257924 | Modulation of GH/IGF-1 axis: potential strategies to counteract sarcopenia in older adults |
| Q36179105 | Molecular and cellular mechanisms of skeletal muscle atrophy: an update. |
| Q39286941 | Molecular effects of exercise training in patients with cardiovascular disease: focus on skeletal muscle, endothelium, and myocardium |
| Q37138465 | Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia |
| Q51631482 | Myocardial expression of FOXO3a-Atrogin-1 pathway in human heart failure. |
| Q30427538 | PGC-1α promotes nitric oxide antioxidant defenses and inhibits FOXO signaling against cardiac cachexia in mice |
| Q42970762 | Protein catabolism and impairment of skeletal muscle insulin signalling in heart failure |
| Q33815408 | SirT1 in muscle physiology and disease: lessons from mouse models. |
| Q38596709 | Skeletal Muscle Changes in Chronic Cardiac Disease and Failure. |
| Q37994970 | Skeletal muscle abnormalities in chronic heart failure |
| Q47937684 | Skeletal muscle alterations in HFrEF vs. HFpEF. |
| Q39090262 | Skeletal muscle inflammation and atrophy in heart failure |
| Q26781640 | Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training |
| Q34697114 | Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training. |
| Q54580129 | Stability of F-box protein atrogin-1 is regulated by p38 mitogen-activated protein kinase pathway in cardiac H9c2 cells. |
| Q36955861 | TNF induction of atrogin-1/MAFbx mRNA depends on Foxo4 expression but not AKT-Foxo1/3 signaling. |
| Q34590981 | Ventricular assist device implantation improves skeletal muscle function, oxidative capacity, and growth hormone/insulin-like growth factor-1 axis signaling in patients with advanced heart failure |
| Q34229899 | mIGF-1/JNK1/SirT1 signaling confers protection against oxidative stress in the heart. |
| Q45084079 | mTORC1 promotes denervation-induced muscle atrophy through a mechanism involving the activation of FoxO and E3 ubiquitin ligases |
| Q35055559 | p300 Acetyltransferase activity differentially regulates the localization and activity of the FOXO homologues in skeletal muscle. |
| Q33574168 | p38 MAPK Participates in Muscle-Specific RING Finger 1-Mediated Atrophy in Cast-Immobilized Rat Gastrocnemius Muscle |
Search more.